E-LIB Suche - Ergebnisse für: Garlich, Joseph R.

1

Dual-activity PI3K–BRD4 inhibitor for the orthogonal inhibi..:

Andrews, Forest H. ; Singh, Alok R. ; Joshi, Shweta...
Proceedings of the National Academy of Sciences of the United States of America. 114 (2017) 7 - p. E1072-E1080 , 2017

Link: https://www.jstor.org/st..

2

Dual-activity PI3K–BRD4 inhibitor for the orthogonal inhibi..:

Andrews, Forest H. ; Singh, Alok R. ; Joshi, Shweta...
Proceedings of the National Academy of Sciences. 114 (2017) 7 - p. , 2017

Link: https://doi.org/10.1073/..

3

Association of high microvessel αvβ3 and low PTEN with poor..:

Erdreich-Epstein, Anat ; Singh, Alok R. ; Joshi, Shweta...
Oncotarget. 8 (2016) 32 - p. 52193-52210 , 2016

Link: https://doi.org/10.18632..

4

PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Ce..:

Singh, Alok R. ; Joshi, Shweta ; Zulcic, Muamera...
PLOS ONE. 11 (2016) 3 - p. e0150836 , 2016

Link: https://doi.org/10.1371/..

5

An integrin-targeted, pan-isoform, phosphoinositide-3 kinas..:

De, Pradip ; Dey, Nandini ; Terakedis, Breanne...
Cancer Chemotherapy and Pharmacology. 71 (2013) 4 - p. 867-881 , 2013

Link: https://doi.org/10.1007/..

6

Synthesis and Cancer Stem Cell-Based Activity of Substitute..:

Morales, Guillermo A. ; Garlich, Joseph R. ; Su, Jingdong...
Journal of Medicinal Chemistry. 56 (2013) 5 - p. 1922-1939 , 2013

Link: https://doi.org/10.1021/..

7

Regiointegrity of carbanions derived by selective metalatio..:

Kaiser, Edwin M. ; Thomas, William R. ; Synos, Terry E....
Journal of Organometallic Chemistry. 213 (1981) 2 - p. 405-417 , 1981

Link: https://doi.org/10.1016/..

8

Macrophage Syk–PI3Kγ Inhibits Antitumor Immunity: SRX3207, ..:

Joshi, Shweta ; Liu, Kevin X ; Zulcic, Muamera...
qt14g4c9wp. , 2020

Link: https://escholarship.org..

9

Macrophage Syk-PI3Kγ inhibits anti-tumor immunity: SRX3207,..:

Joshi, Shweta ; Liu, Kevin X ; Zulcic, Muamera...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450492/. , 2020

Link: http://www.ncbi.nlm.nih...

10

SF2523: Dual PI3K/BRD4 inhibitor blocks tumor immunosuppres..:

Joshi, Shweta ; Singh, Alok R ; Liu, Kevin X...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893301/. , 2019

Link: http://www.ncbi.nlm.nih...

11

SF2523: Dual PI3K/BRD4 Inhibitor Blocks Tumor Immunosuppres..:

Joshi, Shweta ; Singh, Alok R ; Liu, Kevin X...
qt7sj6f8cd. , 2019

Link: https://escholarship.org..

12

Dual-activity PI3K–BRD4 inhibitor for the orthogonal inhibi..:

Andrews, Forest H ; Singh, Alok R ; Joshi, Shweta...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320964/. , 2017

Link: http://www.ncbi.nlm.nih...

13

PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Ce..:

Singh, Alok R ; Joshi, Shweta ; Zulcic, Muamera...
qt7j26329w. , 2016

Link: https://escholarship.org..

14

Association of high microvessel αvβ3 and low PTEN with poor..:

Erdreich-Epstein, Anat ; Singh, Alok R ; Joshi, Shweta...
Publisher's version. , 2016

Link: http://hdl.handle.net/10..

15

Single Agent and Synergistic Activity of the "First-in-Clas..:

Singh, Alok R ; Joshi, Shweta ; Burgoyne, Adam M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278767/. , 2016

Link: http://www.ncbi.nlm.nih...